CTOs on the Move

Mattson Jack Group

www.mattsonjack.com

 
Mattson Jack Group is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Louis, MO. To find more information about Mattson Jack Group, please visit www.mattsonjack.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.mattsonjack.com
  • 11960 Westline Industrial Dr Ste 180
    Saint Louis, MO USA 63146-3212
  • Phone: 314.469.7600

Executives

Name Title Contact Details

Similar Companies

American Red Cross - St. Paul Area

American Red Cross - St. Paul Area is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Washington Radiology Assoc

Washington Radiology Assoc is a Sterling, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atkinson'S Healthcare Prvdrs

Atkinson'S Healthcare Prvdrs is a Orange Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Curo Health Services

At Curo, we are committed to clinical excellence and integrity, insuring our patients the highest quality of care and comfort. To maintain this commitment we hire only the most experienced and capable hospice and home health care professionals. Our clinical team members are experts in pain and symptom management, and our support team members are skilled in the specific issues of emotional support, spiritual counseling, and resource referral.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.